Key result
CPIC gene-drug interactions linked to ~33% higher risk of 90-day hospital readmission.
Why the study?
CPIC guidelines exist for many medications prescribed prior to discharge, but data are limited on how gene-drug interactions contribute to hospital readmissions.
Does the presence of pharmacogenetic gene-x-drug interactions increase the risk of 90-day hospital readmission?
Observational (n=10,104)
No
Does the presence of pharmacogenetic gene-x-drug interactions increase the risk of 90-day hospital readmission?
Pharmacogenetic gene-x-drug interactions for medications prescribed prior to discharge are independently associated with a 33% increased risk of 90-day hospital readmission.
Answers are grounded in this paper and cite their sources.
Gene-drug interactions may raise readmission risk after discharge; leaves open whether preemptive testing improves outcomes in trials.
Clinical Pharmacogenomics Implementation Consortium (CPIC) guidelines exist for many medications commonly prescribed prior to hospital discharge, yet there is limited data regarding the contribution of gene-x-drug interactions to hospital readmissions. The present study evaluated the relationship between prescription of CPIC medications prescribed within 30 days of hospital admission and 90-day hospital readmission from 2010-2020 in a study population (N=10,104) who underwent sequencing with a 14-gene pharmacogenetic panel. The presence of at least one pharmacogenetic indicator for a medication prescribed within 30 days of hospital admission was considered a gene-x-drug interaction. Multivariable logistic regression analyzed the association between one or more gene-x-drug interactions with 90-day readmission. There were 2,211/2,354 (93.9%) admitted patients who were prescribed at least one CPIC medication. Univariate analyses indicated that the presence of at least one identified gene-x-drug interaction increased risk of 90-day readmission by more than 40% (OR=1.42, 95% confidence interval (CI) 1.09-1.84)( p =0.01). A multivariable model adjusting for age, race, sex, employment status, body mass index, and medical conditions, slightly attenuated the effect (OR=1.33, 95% CI 1.02-1.75)( p =0.04). Our results suggest that the presence of one or more CPIC gene-x-drug interactions increases the risk of 90-day hospital readmission, even after adjustment for demographic and clinical risk factors.
No takes yet. Share an insight, caveat, or question.
David et al. (2021) conducted an observational in Hospital Readmission (n=10,104). Presence of at least one CPIC gene-x-drug interaction vs. Prescription of CPIC medication with no gene-x-drug interactions was evaluated on 90-day hospital readmission (OR 1.33, 95% CI 1.02-1.75, p=0.04). The presence of one or more CPIC gene-x-drug interactions increased the risk of 90-day hospital readmission compared to no gene-x-drug interactions.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: